canrenone has been researched along with ouabain in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (64.71) | 18.7374 |
| 1990's | 4 (23.53) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clough, DL; Haddy, FJ; Pamnani, MB; Whitehorn, WV | 1 |
| Facchinetti, A; Finotti, P; Palatini, P | 1 |
| Garay, R; Hannaert, P; Thormann, B | 1 |
| Haddy, FJ; Pamnani, MB | 1 |
| Abitbol, JP; Garay, R; Girerd, X; Hannaert, P; Laurent, S; Safar, M | 1 |
| Boero, R; Deabate, MC; Guarena, C; Piccoli, G; Quarello, F; Rolando, B; Rosati, C | 1 |
| Karlish, SJ; Tal, DM | 1 |
| Boero, R; Deabate, MC; Forneris, G; Guarena, C; Piccoli, G; Quarello, F; Rosati, C | 1 |
| De Mendonca, M; Devynck, MA; Garay, R; Grichois, ML; Meyer, P; Pernollet, MG; Thorman, B | 1 |
| Abitbol, JP; Dagher, G; Diez, J; Garay, RP; Nazaret, C | 1 |
| de Mendonça, M; Devynck, MA; Garay, RP; Grichois, ML; Meyer, P; Pernollet, MG; Thormann, B; Wauquier, I | 1 |
| Finotti, P; Palatini, P | 1 |
| Mügge, A; Schmitz, W; Scholz, H | 1 |
| Andriuoli, G; Calignano, A; Cirino, G; Mancuso, F; Pinto, A; Sorrentino, L; Sorrentino, R | 1 |
| França, A; Rossoni, LV; Stefanon, I; Vassallo, DV; Vassallo, PF | 1 |
| Bova, S; Cargnelli, G; Debetto, P; Luciani, S; Trevisi, L | 1 |
| Bagrov, AY; Cooper, CJ; El-Okdi, N; Elkareh, J; Fedorova, OV; Gohara, S; Gupta, S; Haller, S; Malhotra, D; Periyasamy, SM; Shapiro, JI; Shidyak, A; Taleb, M; Tian, J; Xie, Z | 1 |
1 review(s) available for canrenone and ouabain
| Article | Year |
|---|---|
Pharmacologic agents for the in vivo detection of vascular sodium transport defects in hypertension.
Topics: Amiloride; Animals; Biological Transport, Active; Canrenone; Humans; Hypertension; Ion Channels; Ouabain; Sodium; Sodium-Potassium-Exchanging ATPase; Vascular Diseases | 1987 |
16 other study(ies) available for canrenone and ouabain
| Article | Year |
|---|---|
Effects of canrenone on blood pressure in rats with reduced renal mass.
Topics: Animals; Biological Transport, Active; Blood Pressure; Canrenone; Hypertension; Injections, Intramuscular; Male; Myocardium; Nephrectomy; Ouabain; Potassium; Pregnadienes; Rats; Rats, Inbred Strains; Renin; Sodium; Sodium-Potassium-Exchanging ATPase | 1990 |
Mechanism of Na+/K(+)-ATPase activation by trypsin and kallikrein.
Topics: Animals; Ca(2+) Mg(2+)-ATPase; Canrenone; Cattle; Dogs; Enzyme Activation; Kallikreins; Kidney; Kinetics; Myocardium; Ouabain; Potassium; Sodium; Sodium-Potassium-Exchanging ATPase; Trypsin | 1990 |
Effect of canrenone on the disturbances of cation handling induced by ouabain in macrophages and vascular smooth muscle cells.
Topics: Animals; Biological Transport; Canrenone; Furosemide; Ion Channels; Macrophages; Mathematics; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Muscle, Smooth, Vascular; Ouabain; Potassium; Pregnadienes; Sodium | 1986 |
[Therapeutic response to canrenone of patients with essential hypertension as a function of sodium transport anomalies and ouabain sensitivity of erythrocytes].
Topics: Biological Transport; Canrenone; Erythrocytes; Female; Humans; Hypertension; Male; Middle Aged; Ouabain; Pregnadienes; Sodium Channels; Time Factors | 1989 |
Erythrocyte Na+, K+ pump inhibition after saline infusion in essentially hypertensive subjects: effects of canrenone administration.
Topics: Adult; Biological Transport, Active; Blood Pressure; Canrenone; Erythrocytes; Extracellular Space; Female; Humans; Hypertension; Male; Middle Aged; Ouabain; Potassium; Pregnadienes; Sodium; Sodium Chloride | 1989 |
Do canrenone and 6,7-dihydroxylated derivatives compete with ouabain at the same site on Na,K-ATPase?
Topics: Antihypertensive Agents; Binding, Competitive; Canrenone; Ouabain; Pregnadienes; Sodium-Potassium-Exchanging ATPase; Structure-Activity Relationship | 1988 |
Effects of saline infusion and canrenone on erythrocyte Na+,K+ pump activity.
Topics: Adult; Canrenone; Erythrocytes; Female; Humans; Hypertension; Infusions, Intravenous; Male; Middle Aged; Ouabain; Pregnadienes; Sodium; Sodium Chloride; Sodium-Potassium-Exchanging ATPase | 1988 |
Hypotensive action of canrenone in a model of hypertension where ouabain-like factors are present.
Topics: Animals; Antihypertensive Agents; Blood Volume; Canrenone; Cardenolides; Digoxin; Erythrocytes; Hypertension, Renal; Male; Ouabain; Rats; Rats, Wistar; Saponins; Sodium; Sodium-Potassium-Exchanging ATPase | 1985 |
The interaction of canrenone with the Na+,K+ pump in human red blood cells.
Topics: Canrenone; Drug Synergism; Erythrocyte Membrane; Humans; Ouabain; Potassium; Pregnadienes; Sodium; Sodium-Potassium-Exchanging ATPase | 1985 |
[Canrenone: an effective antihypertensive in an experimental model of hypertension in which the active transport of sodium is diminished].
Topics: Animals; Antihypertensive Agents; Canrenone; Cell Membrane Permeability; Creatinine; Diuresis; Hypertension; Male; Natriuresis; Ouabain; Pregnadienes; Rats; Renin; Sodium; Urea | 1986 |
Canrenone as a partial agonist at the digitalis receptor site of sodium-potassium-activated adenosine triphosphatase.
Topics: 4-Nitrophenylphosphatase; Animals; Canrenoic Acid; Canrenone; Guinea Pigs; In Vitro Techniques; Ouabain; Potassium; Pregnadienes; Protein Binding; Receptors, Drug; Sodium-Potassium-Exchanging ATPase; Spironolactone | 1981 |
Negative inotropic effects of aldosterone antagonists in isolated human and guinea-pig ventricular heart muscle.
Topics: Animals; Canrenoic Acid; Canrenone; Drug Interactions; Guinea Pigs; Heart Ventricles; Humans; Mineralocorticoid Receptor Antagonists; Myocardial Contraction; Ouabain | 1984 |
Increase in the basal tone of guinea pig thoracic aorta induced by ouabain is inhibited by spironolactone canrenone and potassium canrenoate.
Topics: Animals; Aorta, Thoracic; Canrenoic Acid; Canrenone; Cardiotonic Agents; Guinea Pigs; In Vitro Techniques; Isotonic Solutions; Muscle, Smooth, Vascular; Ouabain; Potassium; Sodium-Potassium-Exchanging ATPase; Spironolactone; Vasoconstriction | 1996 |
Small doses of canrenone block the effects of ouabain on the mechanical activity of the heart and vessels of the rat.
Topics: Animals; Blood Pressure; Canrenone; Dose-Response Relationship, Drug; Male; Myocardial Contraction; Ouabain; Papillary Muscles; Phenylephrine; Rats; Rats, Wistar; Sodium-Potassium-Exchanging ATPase | 1998 |
Effects of canrenone on aorta and right ventricle of the rat.
Topics: Animals; Aorta, Thoracic; Calcium; Canrenone; Cardiotonic Agents; Dose-Response Relationship, Drug; Heart Ventricles; Mineralocorticoid Receptor Antagonists; Muscle, Smooth, Vascular; Myocardial Contraction; Ouabain; Phenylephrine; Rats; Rats, Wistar; Ventricular Function | 2001 |
Spironolactone attenuates experimental uremic cardiomyopathy by antagonizing marinobufagenin.
Topics: Animals; Bufanolides; Canrenone; Cardiomyopathies; Cardiotonic Agents; Cells, Cultured; Disease Models, Animal; Drug Interactions; Endomyocardial Fibrosis; Fibroblasts; Mineralocorticoid Receptor Antagonists; Myocardium; Nephrectomy; Ouabain; Procollagen; Proline; Rats; Renal Insufficiency; Spironolactone; Tritium; Uremia | 2009 |